Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Classifying the Progression of Ductal Carcinoma from Single-Cell Sampled Data via Integer Linear Programming: A Case Study.

Catanzaro D, Shackney SE, Schaffer AA, Schwartz R.

IEEE/ACM Trans Comput Biol Bioinform. 2016 Jul-Aug;13(4):643-55. doi: 10.1109/TCBB.2015.2476808. Epub 2015 Sep 4.

2.

A Novel Subset of Human Tumors That Simultaneously Overexpress Multiple E2F-responsive Genes Found in Breast, Ovarian, and Prostate Cancers.

Shackney SE, Chowdhury SA, Schwartz R.

Cancer Inform. 2014 Nov 3;13(Suppl 5):89-100. doi: 10.4137/CIN.S14062. eCollection 2014.

3.

Algorithms to model single gene, single chromosome, and whole genome copy number changes jointly in tumor phylogenetics.

Chowdhury SA, Shackney SE, Heselmeyer-Haddad K, Ried T, Schäffer AA, Schwartz R.

PLoS Comput Biol. 2014 Jul 31;10(7):e1003740. doi: 10.1371/journal.pcbi.1003740. eCollection 2014 Jul.

4.

Phylogenetic analysis of multiprobe fluorescence in situ hybridization data from tumor cell populations.

Chowdhury SA, Shackney SE, Heselmeyer-Haddad K, Ried T, Schäffer AA, Schwartz R.

Bioinformatics. 2013 Jul 1;29(13):i189-98. doi: 10.1093/bioinformatics/btt205.

5.

Applying unmixing to gene expression data for tumor phylogeny inference.

Schwartz R, Shackney SE.

BMC Bioinformatics. 2010 Jan 20;11:42. doi: 10.1186/1471-2105-11-42.

6.
7.

HER2 expression as a potential marker for response to therapy targeted to the EGFR.

Emlet DR, Schwartz R, Brown KA, Pollice AA, Smith CA, Shackney SE.

Br J Cancer. 2006 Apr 24;94(8):1144-53.

8.

A simple correction for cell autofluorescence for multiparameter cell-based analysis of human solid tumors.

Smith CA, Pollice A, Emlet D, Shackney SE.

Cytometry B Clin Cytom. 2006 Mar;70(2):91-103.

10.

Intracellular patterns of Her-2/neu, ras, and ploidy abnormalities in primary human breast cancers predict postoperative clinical disease-free survival.

Shackney SE, Smith CA, Pollice A, Brown K, Day R, Julian T, Silverman JF.

Clin Cancer Res. 2004 May 1;10(9):3042-52.

11.
12.

Molecular evolutionary patterns in breast cancer.

Shackney SE, Silverman JF.

Adv Anat Pathol. 2003 Sep;10(5):278-90. Review.

PMID:
12973049
13.

Reconstruction of geno-phenotypic evolutionary sequences from intracellular patterns of molecular abnormalities in human solid tumors.

Shackney SE, Smith CA, Pollice AA, Silverman JF.

Methods Mol Med. 2003;75:431-49. No abstract available.

PMID:
12407758
14.

Emerging technology and future developments in flow cytometry.

Stewart CC, Goolsby C, Shackney SE.

Hematol Oncol Clin North Am. 2002 Apr;16(2):477-95, vii-viii. Review.

PMID:
12094480
15.

Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.

Han H, Landreneau RJ, Santucci TS, Tung MY, Macherey RS, Shackney SE, Sturgis CD, Raab SS, Silverman JF.

Hum Pathol. 2002 Jan;33(1):105-10.

PMID:
11823980
16.

Distinctive patterns of Her-2/neu, c-myc, and cyclin D1 gene amplification by fluorescence in situ hybridization in primary human breast cancers.

Janocko LE, Brown KA, Smith CA, Gu LP, Pollice AA, Singh SG, Julian T, Wolmark N, Sweeney L, Silverman JF, Shackney SE.

Cytometry. 2001 Jun 15;46(3):136-49.

PMID:
11449404
17.

Selective estrogen receptor modulators. An aid in unraveling the links between estrogen and breast cancer.

Fuqua SA, Russo J, Shackney SE, Stearns ME.

Postgrad Med. 2001 Mar;Spec No:3-10. Review.

PMID:
11296736
18.

Multiparameter analysis of human epithelial tumor cell lines by laser scanning cytometry.

Pollice AA, Smith CA, Brown K, Farkas DL, Silverman JF, Shackney SE.

Cytometry. 2000 Dec 15;42(6):347-56.

PMID:
11135288
19.

Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.

Smith CA, Pollice AA, Gu LP, Brown KA, Singh SG, Janocko LE, Johnson R, Julian T, Hyams D, Wolmark N, Sweeney L, Silverman JF, Shackney SE.

Clin Cancer Res. 2000 Jan;6(1):112-26.

20.

Cell cycle models for molecular biology and molecular oncology: exploring new dimensions.

Shackney SE, Shankey TV.

Cytometry. 1999 Feb 1;35(2):97-116. Review.

PMID:
10554165
21.

Genetic evolutionary staging of early non-small cell lung cancer: the P53 --> HER-2/NEU --> ras sequence.

Shackney SE, Smith CA, Pollice A, Levitt M, Magovern JA, Wiechmann RJ, Silverman J, Sweeney L, Landreneau RJ.

J Thorac Cardiovasc Surg. 1999 Aug;118(2):259-67.

22.
23.

Common patterns of genetic evolution in human solid tumors.

Shackney SE, Shankey TV.

Cytometry. 1997 Sep 1;29(1):1-27. Review.

PMID:
9298807
24.

Correction for antibody crosstalk.

Shackney SE.

Cytometry. 1996 Sep 1;25(1):109-10. No abstract available.

25.

The accumulation of multiple genetic abnormalities in individual tumor cells in human breast cancers: clinical prognostic implications.

Shackney SE, Pollice AA, Smith CA, Alston L, Singh SG, Janocko LE, Brown KA, Petruolo S, Groft DW, Yakulis R, Hartsock RJ.

Cancer J Sci Am. 1996 Mar-Apr;2(2):106-13.

PMID:
9166508
26.

Origins and clinical implications of aneuploidy in early bladder cancer.

Shackney SE, Berg G, Simon SR, Cohen J, Amina S, Pommersheim W, Yakulis R, Wang S, Uhl M, Smith CA, et al.

Cytometry. 1995 Dec 15;22(4):307-16.

27.

Aneuploidy in breast cancer: a fluorescence in situ hybridization study.

Shackney SE, Singh SG, Yakulis R, Smith CA, Pollice AA, Petruolo S, Waggoner A, Hartsock RJ.

Cytometry. 1995 Dec 15;22(4):282-91.

28.

Preferred genetic evolutionary sequences in human breast cancer: a case study.

Shackney SE, Smith CA, Pollice AA, Janocko LE, Singh SG, Groft DW, Brown KA, Hartsock RJ.

Cytometry. 1995 Sep 1;21(1):6-13.

29.

Analytical approaches relating genetic evolutionary pathways to prognostic factors.

Rohloff AC, Sakach JM, Shackney SE.

Cytometry. 1995 Sep 1;21(1):23-9.

30.

Genetic and phenotypic heterogeneity of human malignancies: finding order in chaos.

Shackney SE, Shankey TV.

Cytometry. 1995 Sep 1;21(1):2-5. Review.

31.

Assessing sequential oncogene amplification in human breast cancer.

Janocko LE, Lucke JF, Groft DW, Brown KA, Smith CA, Pollice AA, Singh SG, Yakulis R, Hartsock RJ, Shackney SE.

Cytometry. 1995 Sep 1;21(1):18-22.

32.

Sequential paraformaldehyde and methanol fixation for simultaneous flow cytometric analysis of DNA, cell surface proteins, and intracellular proteins.

Pollice AA, McCoy JP Jr, Shackney SE, Smith CA, Agarwal J, Burholt DR, Janocko LE, Hornicek FJ, Singh SG, Hartsock RJ.

Cytometry. 1992;13(4):432-44.

33.

Flow cytometric S fraction as a predictor of clinical outcome in cystosarcoma phyllodes.

Palko MJ, Wang SE, Shackney SE, Cottington EM, Levitt SB, Hartsock RJ.

Arch Pathol Lab Med. 1990 Sep;114(9):949-52.

PMID:
2167652
34.

ViVACCy--a drug schedule based on G2 blockade and prolonged infusion of multiple tubulin-binding agents. A pilot study.

Shackney SE, Pugh RP, Zidar BL, Raju RN, Simon SR, Mazur RN, Mucenski JW.

Cancer. 1990 Aug 1;66(3):411-7.

PMID:
2194639
35.

Discrepancies between flow cytometric and cytogenetic studies in the detection of aneuploidy in human solid tumors.

Shackney SE, Burholt DR, Pollice AA, Smith CA, Pugh RP, Hartsock RJ.

Cytometry. 1990;11(1):94-104.

36.

Karyotypic evolution of a human undifferentiated large cell carcinoma of the lung in tissue culture.

Burholt DR, Shackney SE, Ketterer DM, Pollice AA, Smith CA, Brown KA, Giles HR, Schepart BS.

Cancer Res. 1989 Jun 15;49(12):3355-61.

37.

Model for the genetic evolution of human solid tumors.

Shackney SE, Smith CA, Miller BW, Burholt DR, Murtha K, Giles HR, Ketterer DM, Pollice AA.

Cancer Res. 1989 Jun 15;49(12):3344-54.

38.

Radiation-induced leiomyosarcoma of the great vessels presenting as superior vena cava syndrome.

Weiss KS, Zidar BL, Wang S, Magovern GJ Sr, Raju RN, Lupetin AR, Shackney SE, Simon SR, Singh M, Pugh RP.

Cancer. 1987 Sep 15;60(6):1238-42.

PMID:
3304612
39.

Pseudo-Gaucher cells in the bone marrow of a patient with Hodgkin's disease.

Zidar BL, Hartsock RJ, Lee RE, Glew RH, LaMarco KL, Pugh RP, Raju RN, Shackney SE.

Am J Clin Pathol. 1987 Apr;87(4):533-6.

PMID:
3103422
40.

Count-dependent filter for smoothing bivariate FCM histograms.

Schuette WH, Shackney SE, Marti GE.

Cytometry. 1986 May;7(3):274-80.

41.
42.
43.

The relationship between mean channel selection and the calculated coefficient of variation.

Schuette WH, Carducci E, Marti GE, Shackney SE, Eden M.

Cytometry. 1985 Sep;6(5):487-91.

44.

Design of flow chamber with electronic cell volume capability and light detection optics for multilaser flow cytometry.

Schuette WH, Shackney SE, Plowman FA, Tipton HW, Smith CA, MacCollum MA.

Cytometry. 1984 Nov;5(6):652-6.

45.

A count-dependent filter for smoothing flow cytometric histograms.

Schuette WH, Shackney SE, MacCollum MA, Smith CA.

Cytometry. 1984 Sep;5(5):487-93.

46.

The biology of tumor growth in the non-Hodgkin's lymphomas. A dual parameter flow cytometry study of 220 cases.

Shackney SE, Levine AM, Fisher RI, Nichols P, Jaffe E, Schuette WH, Simon R, Smith CA, Occhipinti SJ, Parker JW, et al.

J Clin Invest. 1984 Apr;73(4):1201-14.

47.

Schedule dependence of vincristine lethality in Sarcoma 180 cells following partial synchronization with hydroxyurea.

Mujagic H, Conger BM, Smith CA, Occhipinti SJ, Schuette WH, Shackney SE.

Cancer Res. 1983 Aug;43(8):3598-603.

48.

Effects of vincristine on cell survival, cell cycle progression, and mitotic accumulation in asynchronously growing Sarcoma 180 cells.

Mujagic H, Chen SS, Geist R, Occhipinti SJ, Conger BM, Smith CA, Schuette WH, Shackney SE.

Cancer Res. 1983 Aug;43(8):3591-7.

49.
50.

Automated radioautographic grain counting. Correction for grain overlap.

Schuette WH, Chen SS, Occhipinti SJ, Mujagic HS, Shackney SE.

Cell Tissue Kinet. 1983 May;16(3):221-7.

PMID:
6340829

Supplemental Content

Loading ...
Support Center